Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Naunyn-Schmiedeberg's archives of pharmacology 20121001

Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

Journal of medicinal chemistry 20120614

The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.

Journal of consulting and clinical psychology 20120601

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

Depression and anxiety 20120601

Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

Journal of medicinal chemistry 20120524

Simultaneous screening of glutathione and cyanide adducts using precursor ion and neutral loss scans-dependent product ion spectral acquisition and data mining tools.

Journal of the American Society for Mass Spectrometry 20120501

Which psychotropic medications induce hepatotoxicity?

General hospital psychiatry 20120101

The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Parkinson's disease 20120101

Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.

Cost effectiveness and resource allocation : C/E 20120101

Comparison of substance use milestones in cannabis- and cocaine-dependent patients.

Journal of addictive diseases 20120101

Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.

PloS one 20120101

Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).

PloS one 20120101

The effects of centralised and specialised intervention in the early course of severe unipolar depressive disorder: a randomised clinical trial.

PloS one 20120101

Resource utilization and costs before and after total joint arthroplasty.

BMC health services research 20120101

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

PloS one 20120101

Sudden death of cardiac origin and psychotropic drugs.

Frontiers in pharmacology 20120101

A Chinese chan-based mind-body intervention improves sleep on patients with depression: a randomized controlled trial.

TheScientificWorldJournal 20120101

Treatment-resistant depression: therapeutic trends, challenges, and future directions.

Patient preference and adherence 20120101

Optimal treatment of social phobia: systematic review and meta-analysis.

Neuropsychiatric disease and treatment 20120101

Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

Oxidative medicine and cellular longevity 20120101

Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.

Journal of rehabilitation research and development 20120101

Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

The Journal of clinical psychiatry 20111201

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20111001

[Depressive disorder, treatment and sexual dysfunction--part II].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20111001

Are patients undergoing treatment of hyperlipidaemia with statins the best candidates for early cardiac rehabilitation?

Archives of medical science : AMS 20111001

Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.

Journal of medicinal chemistry 20110922

Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia.

Pharmacoepidemiology and drug safety 20110901

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

The Australian and New Zealand journal of psychiatry 20110901

The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.

Clinics (Sao Paulo, Brazil) 20110901

Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.

The Journal of clinical psychiatry 20110801

Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation.

Drug metabolism and disposition: the biological fate of chemicals 20110801

Duloxetine for depression and the incidence of hepatic events in adults.

Journal of clinical psychopharmacology 20110801

Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.

International journal of clinical pharmacy 20110601

Post-operative Changes of Cerebral Glucose Metabolism in Patients with Lumbar Spinal Stenosis with Pre-operative Anxiety: Statistical Parametric Mapping Analysis of F-18 FDG Brain PET.

Asian spine journal 20110601

The association of major depressive episode and personality traits in patients with fibromyalgia.

Clinics (Sao Paulo, Brazil) 20110601

Visual trails: do the doors of perception open periodically?

PLoS biology 20110501

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.

The international journal of neuropsychopharmacology 20110401

Antidepressant drugs and breastfeeding: a review of the literature.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 20110401

The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.

The journal of sexual medicine 20110401

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.

The Journal of clinical psychiatry 20110401

Long-term body weight outcomes of antidepressant-environment interactions.

Molecular psychiatry 20110301

Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.

Pharmacogenomics 20110301

The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.

European journal of pharmacology 20110125

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

The British journal of psychiatry : the journal of mental science 20110101

The societal costs of insomnia.

Neuropsychiatric disease and treatment 20110101

Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.

Breast cancer : basic and clinical research 20110101

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.

Neuropsychiatric disease and treatment 20110101

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Journal of pharmacy & bioallied sciences 20110101

Pharmacogenetics of antidepressants.

Frontiers in pharmacology 20110101

Tolvaptan, hyponatremia, and heart failure.

International journal of nephrology and renovascular disease 20110101

Dysthymia and apathy: diagnosis and treatment.

Depression research and treatment 20110101

Depression in vascular pathologies: the neurologist's point of view.

Vascular health and risk management 20110101

Comparative efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early onset chronic depression: design and rationale of a multisite randomized controlled trial.

BMC psychiatry 20110101

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder.

Harvard review of psychiatry 20110101

Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.

Trials 20110101

Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.

BMC psychiatry 20110101

Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus.

Journal of pharmacology & pharmacotherapeutics 20110101

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission.

Frontiers in molecular neuroscience 20110101

Choosing a gliptin.

Indian journal of endocrinology and metabolism 20110101

Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.

PloS one 20110101

Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study.

BMC pulmonary medicine 20110101

Parasomnias and antidepressant therapy: a review of the literature.

Frontiers in psychiatry 20110101

Chronic depression: development and evaluation of the luebeck questionnaire for recording preoperational thinking (LQPT).

BMC psychiatry 20110101

Critical appraisal of ticagrelor in the management of acute coronary syndrome.

Therapeutics and clinical risk management 20110101

Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma.

Frontiers in endocrinology 20110101

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug metabolism and disposition: the biological fate of chemicals 20101201

Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.

Maturitas 20101201

Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Healthcare informatics research 20101201

Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Journal of toxicologic pathology 20101201

In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.

Drug metabolism and disposition: the biological fate of chemicals 20101001

Best practice guide for the treatment of nightmare disorder in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100815

Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20100801

Effect of trazodone and nefazodone on hepatic injury induced by carbon tetrachloride.

Drug discoveries & therapeutics 20100801

Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone.

Pain medicine (Malden, Mass.) 20100701

Treatment of depression in patients from ethnic minority groups in the Netherlands.

Transcultural psychiatry 20100701

Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis.

Biological psychiatry 20100601

Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

Current treatment options in cardiovascular medicine 20100601

Differential effects of treatments for chronic depression: a latent growth model reanalysis.

Journal of consulting and clinical psychology 20100601

Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum?

Dialogues in clinical neuroscience 20100601

5-(4-Chloro-phen-yl)-3-(2,4-dimethyl-thiazol-5-yl)-1,2,4-triazolo[3,4-a]isoquinoline.

Acta crystallographica. Section E, Structure reports online 20100501

Utility of multivariate analysis in support of in vitro metabolite identification studies: retrospective analysis using the antidepressant drug nefazodone.

Xenobiotica; the fate of foreign compounds in biological systems 20100401

Chronic thromboembolic pulmonary hypertension.

Current treatment options in cardiovascular medicine 20100401

Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.

Psychological medicine 20100301

Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting.

Psychiatry investigation 20100301

Biological contribution to social influences on alcohol drinking: evidence from animal models.

International journal of environmental research and public health 20100201

Depression, suicidality and antidepressants: A coincidence?

Indian journal of psychiatry 20100101

Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

BMC psychiatry 20100101

Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data.

BMC bioinformatics 20100101

Trazodone effects on [H]-paroxetine and alpha(2)-adrenoreceptors in platelets of patients with major depression.

Neuropsychiatric disease and treatment 20100101

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

BMC neurology 20100101

Network-based relating pharmacological and genomic spaces for drug target identification.

PloS one 20100101

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.

Vascular health and risk management 20100101

Getting the balance right: Established and emerging therapies for major depressive disorders.

Neuropsychiatric disease and treatment 20100101

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Vascular health and risk management 20100101

Development of an intervention program to increase effective behaviours by patients and clinicians in psychiatric services: Intervention Mapping study.

BMC health services research 20100101

Drug interaction and pharmacist.

Journal of young pharmacists : JYP 20100101

Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON).

BMC psychiatry 20100101

Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction.

General hospital psychiatry 20100101

Joining the dots: neurobiological links in a functional analysis of depression.

Behavioral and brain functions : BBF 20100101

3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.

Scientia pharmaceutica 20100101

Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study.

PloS one 20100101

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.

Frontiers in psychiatry 20100101

Saxagliptin for type 2 diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

Drug, healthcare and patient safety 20100101

Post-traumatic stress disorder.

BMJ clinical evidence 20100101

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.

Journal of blood medicine 20100101

Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.

Drug metabolism and disposition: the biological fate of chemicals 20091201

Applications of high content screening in life science research.

Combinatorial chemistry & high throughput screening 20091101

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders.

Arthritis and rheumatism 20091015

Physical binding pocket induction for affinity prediction.

Journal of medicinal chemistry 20091008

Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.

Journal of affective disorders 20091001

Accuracy of Veterans Affairs databases for diagnoses of chronic diseases.

Preventing chronic disease 20091001

Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.

Journal of sleep research 20090901

Treatment of sleep dysfunction and psychiatric disorders.

Current treatment options in neurology 20090901

Can drug safety be predicted and animal experiments reduced by using isolated mitochondrial fractions?

Alternatives to laboratory animals : ATLA 20090901

The relationship between concurrent substance use disorders and eating disorders with personality disorders.

International journal of environmental research and public health 20090701

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.

Toxicology and applied pharmacology 20090615

Neuroimaging in anxiety disorders.

Journal of neural transmission (Vienna, Austria : 1996) 20090601

Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study.

Behaviour research and therapy 20090501

Generic dealkylation: a tool for increasing the hit-rate of metabolite rationalization, and automatic customization of mass defect filters.

Rapid communications in mass spectrometry : RCM 20090401

Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20090401

Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.

The Journal of clinical psychiatry 20090301

Psychoactive medication and traffic safety.

International journal of environmental research and public health 20090301

Depression in patients with heart failure: clinical implications and management.

Pharmacotherapy 20090101

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

The American journal on addictions 20090101

Panic disorder: is the PAG involved?

Neural plasticity 20090101

Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.

Neuropsychiatric disease and treatment 20090101

Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

Neuropsychiatric disease and treatment 20090101

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

BMJ (Clinical research ed.) 20090101

Early stage and long term treatment of multiple sclerosis with interferon-beta.

Biologics : targets & therapy 20090101

Interactions between herbal medicines and prescribed drugs: an updated systematic review.

Drugs 20090101

More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

Indian journal of psychiatry 20090101

A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Clinical pharmacokinetics 20090101

Drugs associated with more suicidal ideations are also associated with more suicide attempts.

PloS one 20090101

Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study.

BMJ (Clinical research ed.) 20090101

Algorithms for the assessment and management of insomnia in primary care.

Patient preference and adherence 20090101

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Therapeutics and clinical risk management 20090101

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Neuropsychiatric disease and treatment 20090101

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Cardiology research and practice 20090101

Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation.

Indian journal of human genetics 20090101

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.

Core evidence 20090101

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.

International journal of women's health 20090101

Mind, brain and psychotherapy.

Indian journal of psychological medicine 20090101

Towards achieving remission in the treatment of depression.

Dialogues in clinical neuroscience 20081201

Treatment strategies to improve and sustain remission in major depressive disorder.

Dialogues in clinical neuroscience 20081201

Toward achieving optimal response: understanding and managing antidepressant side effects.

Dialogues in clinical neuroscience 20081201

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

Dialogues in clinical neuroscience 20081201

Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications.

Dialogues in clinical neuroscience 20081201

Triple reuptake inhibitors: the next generation of antidepressants.

Current neuropharmacology 20081201

Interpersonal styles of chronically depressed outpatients: Profiles and therapeutic change.

Psychotherapy (Chicago, Ill.) 20081201

Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

Annals of internal medicine 20081118

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Annals of internal medicine 20081118

Cellular imaging predictions of clinical drug-induced liver injury.

Toxicological sciences : an official journal of the Society of Toxicology 20080901

Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon.

Diabetologia 20080901

Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

Chemical research in toxicology 20080901

Towards a scientific taxonomy of depression.

Dialogues in clinical neuroscience 20080901

Sleep disorders as core symptoms of depression.

Dialogues in clinical neuroscience 20080901

Triple reuptake inhibitors: a premise and promise.

Psychiatry investigation 20080901

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Clinical therapeutics 20080701

Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus.

British journal of cancer 20080603

Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.

Drug metabolism and disposition: the biological fate of chemicals 20080601

In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.

Toxicological sciences : an official journal of the Society of Toxicology 20080601

Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.

Journal of consulting and clinical psychology 20080601

Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.

Drug metabolism and disposition: the biological fate of chemicals 20080501

How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.

Journal of psychiatric practice 20080501

Do new-generation antidepressants work?

Irish medical journal 20080501

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.

Acta psychiatrica Scandinavica 20080401

Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.

Molecular pharmacology 20080301

Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.

The journal of sexual medicine 20080201

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

PLoS medicine 20080201

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?

Neuropsychiatric disease and treatment 20080201

Pharmacological management of panic disorder.

Neuropsychiatric disease and treatment 20080201

Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.

Malaria journal 20080101

Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.

BMC psychiatry 20080101

The impact of mental illness on sexual dysfunction.

Advances in psychosomatic medicine 20080101

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

Philosophy, ethics, and humanities in medicine : PEHM 20080101

Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review.

BioPsychoSocial medicine 20080101

Helpful and hindering factors for remission in dysthymia and panic disorder at 9-year follow-up: a mixed methods study.

BMC psychiatry 20080101

Managing the patient with co-morbid depression and an anxiety disorder.

Drugs 20080101

The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial.

BMC psychiatry 20080101

Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice.

Annals of general psychiatry 20080101

Marijuana neurobiology and treatment.

Substance abuse 20080101

Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective.

Child and adolescent psychiatry and mental health 20080101

Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.

Pharmacological reports : PR 20080101

Continuing medical education.

Indian journal of psychiatry 20080101

Agenda for specialty section in addiction medicine.

Indian journal of psychiatry 20080101

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.

Journal of affective disorders 20071201

Marijuana dependence and its treatment.

Addiction science & clinical practice 20071201

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

The international journal of neuropsychopharmacology 20071001

A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.

European psychiatry : the journal of the Association of European Psychiatrists 20071001

Treatment of depression in cancer patients.

Current oncology (Toronto, Ont.) 20071001

Eszopiclone for late-life insomnia.

Clinical interventions in aging 20070901

Pharmacologic management of overactive bladder.

Clinical interventions in aging 20070901

Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070815

N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed.

Current drug metabolism 20070801

Agomelatine and its therapeutic potential in the depressed patient.

Neuropsychiatric disease and treatment 20070801

Post-traumatic stress disorder.

BMJ clinical evidence 20070801

Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.

The American journal of psychiatry 20070701

Antidepressant-induced liver injury.

The Annals of pharmacotherapy 20070701

Serzone semantics.

Journal of psychosocial nursing and mental health services 20070601

Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.

JPMA. The Journal of the Pakistan Medical Association 20070501

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

JAMA 20070418

High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.

Journal of pharmaceutical and biomedical analysis 20070411

Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.

The international journal of neuropsychopharmacology 20070201

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

Psychopharmacology 20070201

Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.

The Journal of clinical psychiatry 20070201

Dropouts versus completers among chronically depressed outpatients.

Journal of affective disorders 20070101

The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events.

American journal of therapeutics 20070101

'N-in-one' strategy for metabolite identification using a liquid chromatography/hybrid triple quadrupole linear ion trap instrument using multiple dependent product ion scans triggered with full mass scan.

Rapid communications in mass spectrometry : RCM 20070101

[Applications and safety of modern antidepressants in patients with liver diseases].

Wiadomosci lekarskie (Warsaw, Poland : 1960) 20070101

General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Clinical pharmacokinetics 20070101

Combination treatment for acute depression is superior only when psychotherapy is added to medication.

Psychotherapy and psychosomatics 20070101

Greater incidence of depression with hypnotic use than with placebo.

BMC psychiatry 20070101

High-field asymmetric waveform ion mobility spectrometry coupled with liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-FAIMS-MS/MS) multi-component bioanalytical method development, performance evaluation and demonstration of the constancy of the compensation voltage with change of mobile phase composition or flow rate.

Rapid communications in mass spectrometry : RCM 20070101

Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms.

Rapid communications in mass spectrometry : RCM 20070101

Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.

Pharmacological reports : PR 20070101

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome.

Core evidence 20070101

Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20061201

Epidemiologic and clinical updates on impulse control disorders: a critical review.

European archives of psychiatry and clinical neuroscience 20061201

Cardiac conduction disturbances after an overdose of nefazodone and gabapentin.

The American journal of emergency medicine 20061101

The neural correlates of social anxiety disorder and response to pharmacotherapy.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061001

Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.

Drug metabolism and disposition: the biological fate of chemicals 20061001

Treatment of sleep dysfunction and psychiatric disorders.

Current treatment options in neurology 20060901

Management of chronic insomnia in elderly persons.

The American journal of geriatric pharmacotherapy 20060601

Future prospects in depression research.

Dialogues in clinical neuroscience 20060601

Treatments in depression.

Dialogues in clinical neuroscience 20060601

Depression and sleep: pathophysiology and treatment.

Dialogues in clinical neuroscience 20060601

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Use of antidepressant medications in relation to the incidence of breast cancer.

British journal of cancer 20060410

The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060401

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

Toxicological sciences : an official journal of the Society of Toxicology 20060401

Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements.

Journal of the American Society for Mass Spectrometry 20060301

Medical management of depression.

The New England journal of medicine 20060209

Perspectives on the efficacy of antidepressants for child and adolescent depression.

PLoS medicine 20060101

Roles and practices of general practitioners and psychiatrists in management of depression in the community.

BMC family practice 20060101

Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.

BMC health services research 20060101

The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression.

Journal of child and adolescent psychopharmacology 20060101

Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Clinical practice and epidemiology in mental health : CP & EMH 20060101

Topiramate in the treatment of compulsive sexual behavior: case report.

BMC psychiatry 20060101

Long-term pharmacotherapy for post-traumatic stress disorder.

CNS drugs 20060101

Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

CNS drugs 20060101

In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions.

Drug metabolism and drug interactions 20060101

Major depressive disorder, antidepressants, and sexual dysfunction.

The Journal of clinical psychiatry 20060101

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

Pharmacoepidemiology and drug safety 20051201

Antidepressants and their effect on sleep.

Human psychopharmacology 20051201

Contribution of sleep research to the development of new antidepressants.

Dialogues in clinical neuroscience 20051201

Sleep disturbances, psychiatric disorders, and psychotropic drugs.

Dialogues in clinical neuroscience 20051201

Combination/augmentation strategies for improving the treatment of depression.

Neuropsychiatric disease and treatment 20051201

Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

Neuropsychiatric disease and treatment 20051201

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials.

Journal of affective disorders 20051101

Mirtazapine-induced arthralgia.

British journal of clinical pharmacology 20051101

Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

Current drug metabolism 20051001

Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Chemical research in toxicology 20051001

Antidepressants and psychotherapy: a clinical research review.

Dialogues in clinical neuroscience 20050901

Predictive validity of the Brazilian version of the Expected Treatment Outcome Scale in cocaine-dependent outpatients at a drug treatment referral center.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20050901

Adverse drug reaction reporting in New Zealand: implications for pharmacists.

Therapeutics and clinical risk management 20050901

Symptom clusters as predictors of late response to antidepressant treatment.

The Journal of clinical psychiatry 20050801

Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.

International journal of clinical pharmacology and therapeutics 20050701

Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4.

Chemico-biological interactions 20050630

Mixed anxiety and depression in older adults: clinical characteristics and management.

Journal of geriatric psychiatry and neurology 20050601

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

Archives of general psychiatry 20050501

Nefazodone for the treatment of postpartum depression.

Archives of women's mental health 20050501

Migraine preventive therapy: current and emerging treatment options.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501

A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.

Journal of medicinal chemistry 20050421

Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.

European journal of clinical pharmacology 20050401

Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial.

Addiction (Abingdon, England) 20050401

[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].

Der Nervenarzt 20050301

Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.

Addiction (Abingdon, England) 20050301

[Three paradigms in the treatment of posttraumatic stress disorder].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050301

Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?

Neuropsychiatric disease and treatment 20050301

What moderator characteristics are associated with better prognosis for depression?

Neuropsychiatric disease and treatment 20050301

Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.

Drug metabolism and disposition: the biological fate of chemicals 20050201

Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201

The relationship between antidepressant medication use and rate of suicide.

Archives of general psychiatry 20050201

Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment.

Neuropharmacology 20050101

Evidence of cost-effective treatments for depression: a systematic review.

Journal of affective disorders 20050101

The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.

Journal of psychiatry & neuroscience : JPN 20050101

Pharmacological treatments of pathological gambling.

Journal of gambling studies 20050101

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.

BMC psychiatry 20050101

Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.

Clinical practice and epidemiology in mental health : CP & EMH 20050101

Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis.

Psychosomatics 20050101

Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver.

Pharmacological reports : PR 20050101

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.

Therapie 20050101

Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction.

Core evidence 20050101

A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.

The international journal of neuropsychopharmacology 20041201

Newer antidepressants in pregnancy: prospective outcome of a case series.

Reproductive toxicology (Elmsford, N.Y.) 20041201

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

Archives of general psychiatry 20041201

[Review of antidepressants from the TCAs to the third generation drugs].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

Incomplete patient drug information still a problem.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20041109

Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Psychopharmacology 20041101

Effects of nefazodone on the development of experimentally induced tumors in stressed rodents.

Psychopharmacology 20041101

[Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring].

Psychiatrische Praxis 20041101

Nefazodone in primary insomnia: an open pilot study.

Progress in neuro-psychopharmacology & biological psychiatry 20041101

Strategies for managing sexual dysfunction induced by antidepressant medication.

The Cochrane database of systematic reviews 20041018

Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.

The Journal of clinical psychiatry 20041001

Preventive migraine therapy: what is new.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20041001

Sexual dysfunction associated with antidepressant drugs.

Expert opinion on drug safety 20040901

'Dopamine-dependent' side effects of selective serotonin reuptake inhibitors: a clinical review.

The Journal of clinical psychiatry 20040801

Prophylactic migraine therapy: emerging treatment options.

Current pain and headache reports 20040601

A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.

Journal of clinical psychopharmacology 20040601

Nefazodone-induced liver failure.

Journal of clinical psychopharmacology 20040601

Use of antidepressant drugs in transplant recipients.

Progress in transplantation (Aliso Viejo, Calif.) 20040601

[Withdrawal of a drug from the market for safety reasons: process and communication].

Praxis 20040505

Seroquel, Serzone and seizures.

Internal medicine journal 20040301

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

International journal of clinical pharmacology and therapeutics 20040301

Nefazodone treatment of comorbid alcohol dependence and major depression.

Alcoholism, clinical and experimental research 20040301

Current perspectives in the management of treatment-resistant depression.

Dialogues in clinical neuroscience 20040301

Sex-dependent modulation of treatment response.

Dialogues in clinical neuroscience 20040301

Poor response to treatment: beyond medication.

Dialogues in clinical neuroscience 20040301

Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.

Journal of clinical psychopharmacology 20040201

A functional-structural model to understand cardiac autonomic nervous system (ANS) dysregulation in affective illness and to elucidate the ANS effects of antidepressive treatment.

European journal of medical research 20040126

The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.

Progress in neuro-psychopharmacology & biological psychiatry 20040101

Nefazodone-associated torsade de pointes.

International journal of cardiology 20040101

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Drugs 20040101

A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.

Depression and anxiety 20040101

Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.

Journal of the American Medical Directors Association 20040101

Using antipsychotic agents in older patients.

The Journal of clinical psychiatry 20040101

Comparative toxicity of citalopram and the newer antidepressants after overdose.

Journal of toxicology. Clinical toxicology 20040101

Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Clinical pharmacokinetics 20040101

Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.

Depression and anxiety 20040101

Tolerability issues during long-term treatment with antidepressants.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites.

Journal of medical Internet research 20040101

[Neurobiology and pharmacotherapy of social phobia].

L'Encephale 20040101

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Drug safety 20040101

Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

Clinical chemistry and laboratory medicine 20040101

[Assessment of CYP2D6 activity as a form of optimizing antidepressant therapy].

Psychiatria polska 20040101

Resolution of the polarisation of ideologies and approaches in psychiatry.

Mens sana monographs 20040101

Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.

Synapse (New York, N.Y.) 20031201

Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.

Journal of consulting and clinical psychology 20031201

Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.

Journal of consulting and clinical psychology 20031201

Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.

Journal of clinical psychopharmacology 20031201

Rapid and simple methods for quantitative analysis of some antidepressant in pharmaceutical formulations by using first derivative spectrophotometry and HPLC.

Farmaco (Societa chimica italiana : 1989) 20031201

Discontinuation symptoms associated with nefazodone.

Journal of psychopharmacology (Oxford, England) 20031201

Nefazodone (Serzone) withdrawn because of hepatotoxicity.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20031125

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

British journal of cancer 20031117

Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.

Journal of clinical pharmacology 20031101

An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031101

Dyskinetopsia during light adaptation associated with nefazodone treatment.

Eye (London, England) 20031101

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.

Biological psychiatry 20031015

Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial.

Journal of clinical psychopharmacology 20031001

Rhabdomyolysis associated with simvastatin-nefazodone therapy.

Southern medical journal 20031001

Metabolic drug interactions with new psychotropic agents.

Fundamental & clinical pharmacology 20031001

Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.

Psychiatry research 20030930

Obsessive-compulsive spectrum disorders.

Dialogues in clinical neuroscience 20030901

A comparison of antidepressant response in younger and older women.

Journal of clinical psychopharmacology 20030801

Disorders of motion and depth.

Neurologic clinics 20030801

Early onset, nefazodone-induced fulminant hepatic failure.

The American journal of gastroenterology 20030701

Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone.

European journal of pharmacology 20030620

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.

Human psychopharmacology 20030601

Open-label nefazodone in patients with a major depressive episode and alcohol dependence.

Progress in neuro-psychopharmacology & biological psychiatry 20030601

Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.

International clinical psychopharmacology 20030501

Central and peripheral vision loss associated with nefazodone usage.

Documenta ophthalmologica. Advances in ophthalmology 20030501

Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.

Psychological medicine 20030501

Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.

Pharmacology, biochemistry, and behavior 20030501

Antidepressant-induced hepatotoxicity.

Expert opinion on drug safety 20030501

Withdrawing drugs: nefazodone, the start of the latest saga.

Lancet (London, England) 20030412

The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.

The Journal of clinical psychiatry 20030401

The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.

Sleep 20030315

Electroanalytical characteristics of piribedil and its differential pulse and square wave voltammetric determination in pharmaceuticals and human serum.

Journal of pharmaceutical and biomedical analysis 20030310

Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway.

Drug metabolism and disposition: the biological fate of chemicals 20030301

Cortical myoclonus during lithium exposure.

Archives of neurology 20030301

A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030301

The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test.

Behavioural pharmacology 20030201

Nefazodone decreases anxiety during marijuana withdrawal in humans.

Psychopharmacology 20030101

Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.

Rapid communications in mass spectrometry : RCM 20030101

Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

The Journal of clinical psychiatry 20030101

[Drug safety. Notes about surveillance].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101

Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.

Journal of toxicology. Clinical toxicology 20030101

The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder.

Depression and anxiety 20030101

Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.

The Journal of clinical psychiatry 20030101

Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.

Journal of analytical toxicology 20030101

A strategy for metabolite identification using triple-quadrupole mass spectrometry with enhanced resolution and accurate mass capability.

Rapid communications in mass spectrometry : RCM 20030101

Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.

Polish journal of pharmacology 20030101

Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

Psychopharmacology bulletin 20030101

An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.

Psychiatry research 20021230

Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20021201

Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs.

Dialogues in clinical neuroscience 20021201

Effects of smoked marijuana in healthy and HIV + marijuana smokers.

Journal of clinical pharmacology 20021101

Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.

The Journal of clinical psychiatry 20021101

Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.

The Journal of pharmacy and pharmacology 20021101

Polysomnographic sleep effects of fluoxetine and nefazodone on a seasonal affective disorder patient.

Sleep medicine 20021101

Effects of nefazodone on voluntary ethanol consumption induced by isolation stress in young and aged rats.

Pharmacology, biochemistry, and behavior 20021001

Antidepressant-induced sexual dysfunction.

The Annals of pharmacotherapy 20021001

Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.

Nutritional neuroscience 20021001

Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.

Transplantation 20020915

Rhabdomyolysis with simvastatin and nefazodone.

The American journal of psychiatry 20020901

Reversible penile priapism associated with nefazodone.

Journal of the American Geriatrics Society 20020901

[Pharmacological justification for the use of new antidepressant drugs].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020901

Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020901

Sleep in posttraumatic stress disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020901

Nefazodone in the treatment of patients with post-traumatic stress disorder.

Expert review of neurotherapeutics 20020901

Psychopharmacology of anxiety disorders.

Dialogues in clinical neuroscience 20020901

Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.

Psychopharmacology 20020801

Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.

The Journal of clinical psychiatry 20020801

Nefazodone and liver damage.

The Harvard mental health letter 20020801

[Acute liver failure in nefazodone therapy? A case report].

Der Nervenarzt 20020701

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.

The British journal of psychiatry : the journal of mental science 20020601

Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.

The Journal of clinical psychiatry 20020601

Optimizing antidepressant treatment: efficacy and tolerability.

International clinical psychopharmacology 20020601

Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Dialogues in clinical neuroscience 20020601

Loratadine/nefazodone interaction.

Clinical pharmacology and therapeutics 20020501

Hepatic adverse reactions associated with nefazodone.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020501

Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

The Journal of clinical psychiatry 20020501

Pharmacological interactions of statins.

Atherosclerosis. Supplements 20020501

Nefazodone treatment of dysthymic disorder an open, long-term, prospective pilot study.

Progress in neuro-psychopharmacology & biological psychiatry 20020501

Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020401

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

Pharmacology, biochemistry, and behavior 20020401

Serzone. Beware of dangerous liver problems.

Nursing 20020401

Prevalence of sexual dysfunction among newer antidepressants.

The Journal of clinical psychiatry 20020401

From the Food and Drug Administration.

JAMA 20020306

New antidepressants in the treatment of neuropathic pain. A review.

Minerva anestesiologica 20020301

Pathophysiology of depression and mechanisms of treatment.

Dialogues in clinical neuroscience 20020301

The clinical pharmacology of depressive states.

Dialogues in clinical neuroscience 20020301

Nefazodone may increase anxiety in panic disorder.

Journal of clinical psychopharmacology 20020201

Hepatotoxicity associated with the new antidepressants.

The Journal of clinical psychiatry 20020201

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.

Biological psychiatry 20020115

Increased premenstrual dosing of nefazodone relieves premenstrual magnification of depression.

Depression and anxiety 20020101

Pharmacology of antidepressants: focus on nefazodone.

The Journal of clinical psychiatry 20020101

Clinical use of nefazodone in major depression: a 6-year perspective.

The Journal of clinical psychiatry 20020101

Overview of psychiatric disorders and the role of newer antidepressants.

The Journal of clinical psychiatry 20020101

Six-year perspectives on the safety and tolerability of nefazodone.

The Journal of clinical psychiatry 20020101

Antidepressant dosing and switching guidelines: focus on nefazodone.

The Journal of clinical psychiatry 20020101

Cost savings with nefazodone in treating depression.

The Journal of clinical psychiatry 20020101

Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ.

Journal of sex & marital therapy 20020101

Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist.

Arzneimittel-Forschung 20020101

Mood disorders in patients with epilepsy: epidemiology and management.

CNS drugs 20020101

Clinically significant drug interactions with antidepressants in the elderly.

Drugs & aging 20020101

Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.

CNS drugs 20020101

An open-label clinical trial of nefazodone in hypochondriasis.

Psychosomatics 20020101

Combination therapy in the treatment of major depressive disorder complicated by fibromyalgia and menopause.

Psychosomatics 20020101

Mechanism of action of antidepressants.

Psychopharmacology bulletin 20020101

Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.

Neuropsychobiology 20020101

Pharmacotherapy of social anxiety disorder at the turn of the millennium.

The Psychiatric clinics of North America 20011201

QTc prolongation and drugs.

Clinical pharmacology and therapeutics 20011201

A probable interaction between a very low-dose oral contraceptive and the antidepressant nefazodone: a case report.

Journal of clinical psychopharmacology 20011201

Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients.

Neuroscience and biobehavioral reviews 20011201

LC determination and purity evaluation of nefazodone HCl in bulk drug and pharmaceutical formulations.

Journal of pharmaceutical and biomedical analysis 20011101

Possible interaction of zopiclone and nefazodone.

The Annals of pharmacotherapy 20011101

[Pharmacotherapeutical approaches to insomnia patients with cardiac diseases and after heart transplantation].

Zeitschrift fur Kardiologie 20011001

An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.

The Journal of clinical psychiatry 20011001

Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.

Expert opinion on pharmacotherapy 20011001

A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.

Journal of psychopharmacology (Oxford, England) 20010901

Antidepressants in social anxiety disorder.

Arquivos de neuro-psiquiatria 20010901

Treatment of somatization disorder with nefazodone: a prospective, open-label study.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20010901

Cognitive toxicity of drugs used in the elderly.

Dialogues in clinical neuroscience 20010901

Opposite effects of nefazodone in two human models of anxiety.

Psychopharmacology 20010801

Nefazodone may inhibit the metabolism of carbamazepine: three case reports.

European psychiatry : the journal of the Association of European Psychiatrists 20010801

[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].

Nihon rinsho. Japanese journal of clinical medicine 20010801

Bupropion and drug-induced parkinsonism.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010801

Efficacy of noradrenergic-selective agents in the treatment of neuropsychiatric diseases.

CNS spectrums 20010801

P-glycoprotein interactions of nefazodone and trazodone in cell culture.

Journal of clinical pharmacology 20010701

Remission of SSRI-induced akathisia after switch to nefazodone.

The Journal of clinical psychiatry 20010701

Open trial of nefazodone for combat veterans with posttraumatic stress disorder.

Journal of traumatic stress 20010701

Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.

Journal of clinical psychopharmacology 20010601

Depression and anxiety disorders.

Obstetrics and gynecology clinics of North America 20010601

The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.

Journal of psychopharmacology (Oxford, England) 20010601

A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction.

The Journal of clinical psychiatry 20010601

[The antidepressant nefazodone. Healthy sleep fosters compliance].

MMW Fortschritte der Medizin 20010528

Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation 20010501

Nefazodone for chronic daily headache prophylaxis: an open-label study.

Headache 20010501

Increase in plasma levels of clozapine and norclozapine after administration of nefazodone.

The Journal of clinical psychiatry 20010501

Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.

Psychopharmacology 20010501

Acute liver failure.

Current opinion in gastroenterology 20010501

Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.

The Journal of clinical psychiatry 20010401

Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry.

Journal of chromatography. B, Biomedical sciences and applications 20010305

Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.

Clinical pharmacology and therapeutics 20010301

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.

Journal of psychopharmacology (Oxford, England) 20010301

Which depressed patients respond to nefazodone and when?

The Journal of clinical psychiatry 20010301

Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20010301

Current trends in the development of new antidepressants.

Current medicinal chemistry 20010201

Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.

Therapeutic drug monitoring 20010201

Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone.

Journal of affective disorders 20010201

Antidepressants as analgesics: a review of randomized controlled trials.

Journal of psychiatry & neuroscience : JPN 20010101

Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

The Journal of clinical psychiatry 20010101

The effects of antidepressants on sexual functioning in depressed patients: a review.

The Journal of clinical psychiatry 20010101

Clinical significance of monitoring early symptom change to predict outcome.

The Journal of clinical psychiatry 20010101

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

The Journal of clinical psychiatry 20010101

Response to nefazodone in a depressed patient with end-stage renal disease.

General hospital psychiatry 20010101

Acute and maintenance treatment of chronic depression.

The Journal of clinical psychiatry 20010101

Algorithm for the treatment of chronic depression.

The Journal of clinical psychiatry 20010101

Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.

Depression and anxiety 20010101

Increased throughput in quantitative bioanalysis using parallel-column liquid chromatography with mass spectrometric detection.

Rapid communications in mass spectrometry : RCM 20010101

Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

CNS drugs 20010101

Depression, sleep physiology, and antidepressant drugs.

Depression and anxiety 20010101

Long-term treatment of recurrent and chronic depression.

The Journal of clinical psychiatry 20010101

Third-generation antidepressants: do they offer advantages over the SSRIs?

CNS drugs 20010101

Interactions between herbal medicines and prescribed drugs: a systematic review.

Drugs 20010101

Pharmacokinetically induced benzodiazepine withdrawal.

Psychopharmacology bulletin 20010101

Charleston Antidepressant Drug Interactions Surveillance Program (CADISP).

Psychopharmacology bulletin 20010101

[Acute liver failure ascribed to nefazodone: importance of 'postmarketing surveillance' for recently introduced drugs].

Nederlands tijdschrift voor geneeskunde 20001007

Nefazodone-induced acute liver failure.

The American journal of gastroenterology 20000601

Reversible nefazodone-induced liver failure.

Digestive diseases and sciences 20000501

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.

Psychopharmacology 19990701

Nefazodone-induced liver failure: report of three cases.

Annals of internal medicine 19990216

Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.

Bioorganic & medicinal chemistry letters 19980303

Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.

Pharmacotherapy 19980101

Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.

The Journal of pharmacology and experimental therapeutics 19971201

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

The Journal of clinical psychiatry 19970501

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.

Drugs 19970401

Serotonin syndrome associated with nefazodone and paroxetine.

Annals of emergency medicine 19970201

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone.

JAMA 19970101

Probable nefazodone-induced mania in a patient with unreported bipolar disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 19961201

Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.

The Journal of clinical psychiatry 19960701

The safety profile of nefazodone.

The Journal of clinical psychiatry 19960101